Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Jinbaoxin Technology Co., Ltd. is a prominent Chinese healthcare technology and medical device company specializing in blood transfusion management and in vitro diagnostics (IVD). Established in 1998, the company offers a comprehensive suite of products including clinical blood management information systems, laboratory information systems (LIS), and diagnostic reagents. Its biotechnology division focuses on the production of microcolumn gel cards and other essential reagents for blood grouping and cross-matching. Jinbaoxin's solutions are integrated into numerous hospitals and blood centers throughout China, playing a critical role in ensuring transfusion safety and operational efficiency. The company is recognized as a pioneer in the 'Closed-loop Blood Transfusion Management' concept within the Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinbaoxin.